Annual CFO
-$85.69 M
-$10.54 M-14.03%
December 31, 2023
Summary
- As of February 8, 2025, ORIC annual cash flow from operations is -$85.69 million, with the most recent change of -$10.54 million (-14.03%) on December 31, 2023.
- During the last 3 years, ORIC annual CFO has fallen by -$40.42 million (-89.29%).
- ORIC annual CFO is now -314.29% below its all-time high of -$20.68 million, reached on December 31, 2018.
Performance
ORIC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$28.80 M
-$3.17 M-12.38%
September 30, 2024
Summary
- As of February 8, 2025, ORIC quarterly cash flow from operations is -$28.80 million, with the most recent change of -$3.17 million (-12.38%) on September 30, 2024.
- Over the past year, ORIC quarterly CFO has dropped by -$9.15 million (-46.59%).
- ORIC quarterly CFO is now -437.26% below its all-time high of -$5.36 million, reached on September 30, 2019.
Performance
ORIC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$108.88 M
-$9.15 M-9.18%
September 30, 2024
Summary
- As of February 8, 2025, ORIC TTM cash flow from operations is -$108.88 million, with the most recent change of -$9.15 million (-9.18%) on September 30, 2024.
- Over the past year, ORIC TTM CFO has dropped by -$32.13 million (-41.87%).
- ORIC TTM CFO is now -1868.50% below its all-time high of -$5.53 million, reached on March 1, 2019.
Performance
ORIC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ORIC Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.0% | -46.6% | -41.9% |
| 3 y3 years | -89.3% | -46.6% | -41.9% |
| 5 y5 years | -314.3% | -46.6% | -41.9% |
ORIC Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -43.9% | at low | -87.9% | +4.6% | -82.9% | at low |
| 5 y | 5-year | -264.1% | at low | -302.9% | +4.6% | -362.7% | at low |
| alltime | all time | -314.3% | at low | -437.3% | +4.6% | -1868.5% | at low |
ORIC Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$28.80 M(+12.4%) | -$108.88 M(+9.2%) |
| Jun 2024 | - | -$25.63 M(-15.1%) | -$99.73 M(+4.7%) |
| Mar 2024 | - | -$30.19 M(+24.4%) | -$95.25 M(+11.2%) |
| Dec 2023 | -$85.69 M(+14.0%) | -$24.27 M(+23.5%) | -$85.69 M(+11.6%) |
| Sep 2023 | - | -$19.64 M(-7.1%) | -$76.75 M(+0.4%) |
| Jun 2023 | - | -$21.14 M(+2.5%) | -$76.42 M(+4.6%) |
| Mar 2023 | - | -$20.63 M(+34.6%) | -$73.05 M(-2.8%) |
| Dec 2022 | -$75.14 M(+26.2%) | -$15.33 M(-20.7%) | -$75.14 M(-1.3%) |
| Sep 2022 | - | -$19.32 M(+8.7%) | -$76.10 M(+10.4%) |
| Jun 2022 | - | -$17.78 M(-21.8%) | -$68.92 M(+2.3%) |
| Mar 2022 | - | -$22.72 M(+39.5%) | -$67.36 M(+13.1%) |
| Dec 2021 | -$59.54 M | -$16.28 M(+34.1%) | -$59.54 M(-2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$12.14 M(-25.1%) | -$61.08 M(+4.4%) |
| Jun 2021 | - | -$16.21 M(+8.8%) | -$58.52 M(+12.8%) |
| Mar 2021 | - | -$14.90 M(-16.4%) | -$51.89 M(+14.6%) |
| Dec 2020 | -$45.27 M(+92.4%) | -$17.82 M(+86.1%) | -$45.27 M(+30.9%) |
| Sep 2020 | - | -$9.58 M(-0.0%) | -$34.59 M(+13.9%) |
| Jun 2020 | - | -$9.58 M(+15.8%) | -$30.37 M(+15.6%) |
| Mar 2020 | - | -$8.28 M(+15.8%) | -$26.28 M(+11.7%) |
| Dec 2019 | -$23.53 M(+13.8%) | -$7.15 M(+33.4%) | -$23.53 M(+43.6%) |
| Sep 2019 | - | -$5.36 M(-2.4%) | -$16.39 M(+48.6%) |
| Jun 2019 | - | -$5.49 M(-0.7%) | -$11.03 M(+99.3%) |
| Mar 2019 | - | -$5.53 M | -$5.53 M |
| Dec 2018 | -$20.68 M | - | - |
FAQ
- What is ORIC Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals annual CFO year-on-year change?
- What is ORIC Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals quarterly CFO year-on-year change?
- What is ORIC Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals TTM CFO year-on-year change?
What is ORIC Pharmaceuticals annual cash flow from operations?
The current annual CFO of ORIC is -$85.69 M
What is the all time high annual CFO for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high annual cash flow from operations is -$20.68 M
What is ORIC Pharmaceuticals annual CFO year-on-year change?
Over the past year, ORIC annual cash flow from operations has changed by -$10.54 M (-14.03%)
What is ORIC Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ORIC is -$28.80 M
What is the all time high quarterly CFO for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high quarterly cash flow from operations is -$5.36 M
What is ORIC Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ORIC quarterly cash flow from operations has changed by -$9.15 M (-46.59%)
What is ORIC Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ORIC is -$108.88 M
What is the all time high TTM CFO for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high TTM cash flow from operations is -$5.53 M
What is ORIC Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ORIC TTM cash flow from operations has changed by -$32.13 M (-41.87%)